ArticleOncotarget2024

Retraction: Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma.

Valerie B Sampson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.